12-114356005-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_181486.4(TBX5):āc.1084C>Gā(p.Gln362Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000301 in 1,461,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_181486.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX5 | NM_181486.4 | c.1084C>G | p.Gln362Glu | missense_variant | 9/9 | ENST00000405440.7 | NP_852259.1 | |
TBX5 | NM_000192.3 | c.1084C>G | p.Gln362Glu | missense_variant | 9/9 | NP_000183.2 | ||
TBX5 | NM_080717.4 | c.934C>G | p.Gln312Glu | missense_variant | 8/8 | NP_542448.1 | ||
TBX5 | XM_017019912.2 | c.1132C>G | p.Gln378Glu | missense_variant | 9/9 | XP_016875401.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX5 | ENST00000405440.7 | c.1084C>G | p.Gln362Glu | missense_variant | 9/9 | 1 | NM_181486.4 | ENSP00000384152.3 | ||
TBX5 | ENST00000310346.8 | c.1084C>G | p.Gln362Glu | missense_variant | 9/9 | 1 | ENSP00000309913.4 | |||
TBX5 | ENST00000349716.9 | c.934C>G | p.Gln312Glu | missense_variant | 8/8 | 1 | ENSP00000337723.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251406Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135862
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461814Hom.: 0 Cov.: 33 AF XY: 0.0000316 AC XY: 23AN XY: 727202
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Aortic valve disease 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 07, 2017 | In summary, this variant is a rare missense change that is not predicted to affect protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. This variant is present in population databases (rs765204502, ExAC 0.001%) but has not been reported in the literature in individuals with a TBX5-related disease. This sequence change replaces glutamine with glutamic acid at codon 362 of the TBX5 protein (p.Gln362Glu). The glutamine residue is moderately conserved and there is a small physicochemical difference between glutamine and glutamic acid. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2019 | The p.Q362E variant (also known as c.1084C>G), located in coding exon 8 of the TBX5 gene, results from a C to G substitution at nucleotide position 1084. The glutamine at codon 362 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at